BURLINGAME, CA--(Marketwire - December 03, 2007) - APT Pharmaceuticals, a specialty drug development company primarily focused on inhaled treatments for serious lung diseases, announced today that Paul Sekhri has joined its Board of Directors, effective immediately.
Mr. Sekhri founded Cerimon Pharmaceuticals in 2005 and currently serves as the company's President and CEO. He is also a board member for ARYx Therapeutics, the Cancer Research Institute and the International Health Organization. Mr. Sekhri's previous positions include President and Chief Business Officer of ARIAD Pharmaceuticals and Senior Vice President and Head of Global Search and Evaluation, Business Development and Licensing, for Novartis Pharma AG.
